Denmark approves wider use of Dupixent for severe asthma in children
The Danish Medicines Council has held a meeting resulting in a new batch of drug approvals for the nation. One of these is for Sanofi/Regeneron’s multi-blockbuster Dupixent.
by christopher due karlsson, translated by daniel pedersen
The Danish Medicines Council, responsible for recommending what medicines the Danish hospital system can take into use, has this week assessed a handful of drugs, turning up with recommendations for three treatments, and one reassessment. But it hasn’t been good news all around – for Astrazeneca in particular.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Year-to date Dupixent sales surpass all of 2021
For subscribers
Leo Pharma's label extension wish granted
For subscribers
Dupixent might halt "the atopic march," research finds
For subscribers
